Document is current
Any future updates will be listed below
-
Authors
Banella, Sabrina
Quarta, Eride
Brandolini, Martina
Grumiro, Laura
Sambri, Vittorio
Trevisi, Giovanna
Bettini, Ruggero
Colombo, Paolo
Buttini, Francesca
Sonvico, Fabio
Caraua, Georgeta
Rossi, Alessandra
Colombo, Gaia https://orcid.org/0000-0001-9033-2305
- License Information
-
More Information
Article History
Accepted: 28 June 2025
First Online: 15 July 2025
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Research Ethics Board of the University of Parma (June 11th, 2024, protocol number 0145714).
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all healthy volunteers for being included in the study.
: Emeritus Professor Paolo Colombo is the administrator of the innovative SME PlumeStars s.r.l., the Applicant of an Italian patent on “Novel Antiviral Compositions and Their Use in Therapy and in the Treatment of Viral Infections” (No. 102021000002003, filed on 01/02/2021). Paolo Colombo, Eride Quarta, Gaia Colombo and Sabrina Banella are the inventors of that patent. Ruggero Bettini and Francesca Buttini, both professors of Pharmaceutical Technology at the Food and Drug Department of the University of Parma, are co-founders of PlumeStars start-up. The other authors have no relevant financial or non-financial interests to disclose.
